NSC |
Compound |
Enrichment |
Correlation |
NSC 750335 |
(E)-3-(2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one |
0.0181211508101519 |
-0.18177145 |
NSC 92915 |
ANTINEOPLASTIC-92915 |
0.0181211508101519 |
0.062770381 |
NSC 228155 |
Null |
0.0187206825450445 |
0.42145299 |
NSC 639517 |
Cyclopentanone, 2-[(4-chlorophenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride |
0.0187206825450445 |
0.47737279 |
NSC 120925 |
Null |
0.0208632511155816 |
0.31918983 |
NSC 132275 |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.0208632511155816 |
0.39474986 |
NSC 132277 |
Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) |
0.0208632511155816 |
0.25809446 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0208632511155816 |
0.095684465 |
NSC 144163 |
Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- |
0.0208632511155816 |
0.31504215 |
NSC 208885 |
Null |
0.0208632511155816 |
-9.2397901e-005 |